The optimal level and modality of glucose control in critically ill patients is still debated. A protocolized approach and the use of nearly-continuous technologies are recommended to manage hyperglycemia, hypoglycemia and glycemic variability (1). We recently proposed a pato-physiology-based glucose control protocol which takes into account patient glucose/carbohydrate intake and insulin resistance
Evaluation of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device / M. Umbrello, M. Cattaneo, L.A. D'Amato, D. Longhi, B. Salihovic, S. Santini, I.R. Piva, I. CUEVAS CAIRO, G. Mistraletti, G. Iapichino, B. MORO SALIHOVIC. ((Intervento presentato al 25. convegno SMART tenutosi a Milano nel 2014.
Evaluation of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device
M. UmbrelloPrimo
;M. CattaneoSecondo
;L.A. D'Amato;D. Longhi;S. Santini;I. CUEVAS CAIRO;G. MistralettiPenultimo
;G. IapichinoUltimo
;B. MORO SALIHOVIC
2014
Abstract
The optimal level and modality of glucose control in critically ill patients is still debated. A protocolized approach and the use of nearly-continuous technologies are recommended to manage hyperglycemia, hypoglycemia and glycemic variability (1). We recently proposed a pato-physiology-based glucose control protocol which takes into account patient glucose/carbohydrate intake and insulin resistance
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
